About Us

Mordi Rabinovich, Ph.D, R.Ph, MBA

Mordi Rabinovich is a leading expert in Market Access, NHB processes and pharmacoeconomics. Formerly Head of the Department of Health Technology Policy at Maccabi Healthcare Services (an Israeli sick-fund insuring 2 million people), Associate Director Market Access & Reimbursement at Gilead Israel and Director of Customer Strategy at AstraZeneca Israel. Holds a Ph.D degree from the Department of Health Systems Management at Ben-Gurion University, B.Pharm from the Hebrew University and MBA degree from Tel-Aviv University. Led the field of Health Technology Assessment in Maccabi HMO related to formulary decisions and NHB updates. Represented Maccabi at the National NHB Committee & economic sub-committee, and coordinated the “Health Technology Forum”, a policy setting forum for drugs and medical technologies in the HMO, headed by the CEO. In his roles at the pharmaceutical industry had overall responsibility of NHB and sick-funds strategy, led NHB and sick-funds reimbursement processes. During his work as an independent consultant led reimbursement processes of dozens of pharmaceutical products and medical devices, with high success rates.

Diana Gurevitch Ph.D, MBA

Diana holds a Ph.D degree from the Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel.
Formerly served as Medical Scientific Liaison in Pfizer (Israel) Ltd., Diana led the pre-launch activities for several new pharmaceutical products.

Diana completed her Post Doctorate Fellowship in the Department of Environmental Science and Energy Research at the Weizmann Institute of Science. She also holds a master degree from the Department of Molecular Genetics at Ben-Gurion University.

Contact Request